Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-04-03

Clinical Trial Update: Safety, Efficacy, and Tolerability of Vilazodone in Major Depressive Disorder [Phase 4]

View source ↗

Summary

Phase 4 clinical trial results evaluating the safety, efficacy, and tolerability of vilazodone in adults with major depressive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Viibryd (vilazodone)

Snippet

Sponsor: Forest Laboratories | Conditions: Major Depressive Disorder | Phase 4 | Status: COMPLETED | Results posted: 2014-04-03